Bath & Body Works, Inc. (NYSE:BBWI) Given Average Rating of "Hold" by Analysts

Key Points

• Analysts rate Bath & Body Works “Hold” on average: Of 18 analysts, 14 recommend holding, three recommend buying and one recommends selling. The average 12-month price target is approximately $21.93.
• Recent results exceeded expectations but weakened year over year: Quarterly EPS was $0.32 versus the $0.29 consensus estimate, while revenue reached $1.38 billion; however, revenue fell 3.2% year over year and prior-year EPS was $0.49.
• The stock traded near $19.33 and offers a 4.1% dividend yield: Shares were down 5.1%, and the company declared a quarterly dividend of $0.20 per share, or $0.80 annualized.

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) has been given an average rating of "Hold" by the eighteen analysts that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, fourteen have issued a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $21.9286.

A number of equities analysts recently weighed in on BBWI shares. The Goldman Sachs Group lowered shares of Bath & Body Works from a "neutral" rating to a "sell" rating and dropped their target price for the stock from $23.00 to $19.00 in a research report on Wednesday, July 8th. Jefferies Financial Group boosted their price target on shares of Bath & Body Works from $22.00 to $23.00 and gave the stock a "hold" rating in a research note on Tuesday, July 28th. Raymond James Financial reissued a "market perform" rating on shares of Bath & Body Works in a report on Wednesday, May 27th. UBS Group cut their price objective on Bath & Body Works from $22.00 to $19.00 and set a "neutral" rating for the company in a research report on Wednesday, May 20th. Finally, Morgan Stanley restated an "equal weight" rating and set a $22.00 price objective on shares of Bath & Body Works in a research report on Monday, July 6th.

Institutional Trading of Bath & Body Works

A number of large investors have recently added to or reduced their stakes in the company. Royal Bank of Canada boosted its position in shares of Bath & Body Works by 92.8% during the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company's stock valued at $1,815,000 after acquiring an additional 28,815 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Bath & Body Works by 15.7% in the first quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company's stock worth $19,586,000 after purchasing an additional 87,529 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Bath & Body Works by 7.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company's stock valued at $17,063,000 after purchasing an additional 36,684 shares in the last quarter. Intech Investment Management LLC purchased a new stake in Bath & Body Works during the first quarter valued at $1,155,000. Finally, Geneos Wealth Management Inc. lifted its position in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 5.1%

Shares of BBWI opened at $19.33 on Tuesday. The business's 50 day moving average is $20.32 and its 200 day moving average is $20.25. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $32.32. The company has a market capitalization of $3.90 billion, a PE ratio of 5.43, a price-to-earnings-growth ratio of 2.01 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. The business had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm's revenue for the quarter was down 3.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities research analysts predict that Bath & Body Works will post 2.63 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 4.1%. Bath & Body Works's dividend payout ratio is presently 22.47%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source